|
|
OTC Healthcare in Greece to 2013
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 190 Pages | |||||||||
| Inhalt der Studie: |
Introduction
This databook provides key data and information on the OTC healthcare market in Greece. This report is a comprehensive resource for market, category and segment level data including valu.....
Introduction This databook provides key data and information on the OTC healthcare market in Greece. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share. Scope *Contains information on:analgesics,medicated skin product,topical OTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits *Market,category and segment level information on value with historic (2003-2008) and forecast (2009-2013) data *Category level company and brand share as well as distribution share information for 2007 and 2008 *Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description Highlights The market for OTC healthcare in Greece increased at a compound annual growth rate of 8.7% between 2003 and 2008. The vitamins and minerals category led the OTC healthcare market in Greece, accounting for a share of 26.2%. Leading players in Greek OTC healthcare market include Johnson & Johnson, Korres Natural Products S.A. and Bayer AG. Reasons to Purchase *Develop business strategies by understanding the quantitative trends within the OTC healthcare market in Greece *Design effective marketing and sales strategies by identifying key market categories and segments *Identify key players within the market to plan lucrative M&A, partnerships and agreements Report Highlights [Studien Infos ausblenden] |
|||||||||||
|
TABLE OF CONTENTS Chapter 1 Executive Summary 2 Summary market level: OTC healthcare 2 Summary category level: analgesics 3 Summary category level: topical OTC medicines 4 Summary category level: cough and cold preparations 5 Summary category level: indigestion preparations 6 Summary category level: medicated skin products 7 Summary category level: first aid kits 8 Summary category level: other OTC healthcare products 9 Summary category level: plasters & bandages 10 Summary category level: traditional medicines 11 Summary category level: vitamins and minerals 12 Chapter 2 Introduction 13 What is this report about? 13 How to use this report 13 Market definition 14 Chapter 3 Market Overview 30 Value analysis (Euro), 2003?08 30 Value analysis (Euro), 2008?13 32 Value analysis (US dollars), 2003?08 34 Value analysis (US dollars), 2008?13 35 Company and brand share analysis 37 Distribution analysis 44 Chapter 4 Leading Company Profiles 46 Johnson & Johnson 46 Bayer AG 48 Chapter 5 Category Analysis: Analgesics 51 Value analysis (Euro), 2003?08 51 Value analysis (Euro), 2008?13 52 Value analysis (US dollars), 2003?08 54 Value analysis (US dollars), 2008?13 55 Company and brand share analysis 57 Distribution analysis 60 Chapter 6 Category Analysis: Topical OTC Medicines 62 Value analysis (Euro), 2003?08 62 Value analysis (Euro), 2008?13 63 Value analysis (US dollars), 2003?08 65 Value analysis (US dollars), 2008?13 66 Company and brand share analysis 68 Distribution analysis 70 Chapter 7 Category Analysis: Cough and Cold Preparations 72 Value analysis (Euro), 2003?08 72 Value analysis (Euro), 2008?13 73 Value analysis (US dollars), 2003?08 75 Value analysis (US dollars), 2008?13 76 Company and brand share analysis 78 Distribution analysis 81 Chapter 8 Category Analysis: Indigestion Preparations 83 Value analysis (Euro), 2003?08 83 Value analysis (Euro), 2008?13 84 Value analysis (US dollars), 2003?08 86 Value analysis (US dollars), 2008?13 86 Company and brand share analysis 88 Distribution analysis 91 Chapter 9 Category Analysis: Medicated Skin Products 93 Value analysis (Euro), 2003?08 93 Value analysis (Euro), 2008?13 94 Value analysis (US dollars), 2003?08 96 Value analysis (US dollars), 2008?13 97 Company and brand share analysis 99 Distribution analysis 102 Chapter 10 Category Analysis: First Aid Kits 104 Value analysis (Euro), 2003?08 104 Value analysis (Euro), 2008?13 105 Value analysis (US dollars), 2003?08 106 Value analysis (US dollars), 2008?13 106 Company and brand share analysis 107 Distribution analysis 110 Chapter 11 Category Analysis: Other OTC Healthcare Products 112 Value analysis (Euro), 2003?08 112 Value analysis (Euro), 2008?13 113 Value analysis (US dollars), 2003?08 115 Value analysis (US dollars), 2008?13 116 Company and brand share analysis 118 Distribution analysis 121 Chapter 12 Category Analysis: Plasters & Bandages 123 Value analysis (Euro), 2003?08 123 Value analysis (Euro), 2008?13 124 Value analysis (US dollars), 2003?08 126 Value analysis (US dollars), 2008?13 127 Company and brand share analysis 129 Distribution analysis 132 Chapter 13 Category Analysis: Traditional Medicines 134 Value analysis (Euro), 2003?08 134 Value analysis (Euro), 2008?13 135 Value analysis (US dollars), 2003?08 136 Value analysis (US dollars), 2008?13 136 Company and brand share analysis 137 Distribution analysis 139 Chapter 14 Category Analysis: Vitamins and Minerals 141 Value analysis (Euro), 2003?08 141 Value analysis (Euro), 2008?13 142 Value analysis (US dollars), 2003?08 144 Value analysis (US dollars), 2008?13 144 Company and brand share analysis 146 Distribution analysis 150 Chapter 15 Country Comparison 152 Value 152 Market share 156 Chapter 16 PESTLE Analysis 157 Summary 157 Political analysis 158 Economic analysis 162 Social analysis 166 Technological analysis 169 Legal analysis 173 Environmental analysis 177 Chapter 17 Macroeconomic Profile 180 Macroeconomic indicators 180 Chapter 18 Research Methodology 185 Methodology overview 185 Secondary research 186 Market modeling 187 Creating an initial data model 187 Revising the initial data model 187 Creating a final estimate 188 Creating demographic value splits 188 Primary research 188 Data finalization 189 Ongoing research 189 Chapter 19 APPENDIX 190 Future readings 190 How to contact experts in your industry 190 Disclaimer 190 LIST OF FIGURES Figure 1: Greece OTC healthcare value and value forecast, 2003?13 (€m, nominal prices) 33 Figure 2: Greece OTC healthcare category growth comparison, by value, 2003?13 36 Figure 3: Greece OTC healthcare company share, by value, 2007?08 (%) 41 Figure 4: Greece OTC healthcare distribution channels, by value, 2007?08 (%) 45 Figure 5: Greece analgesics value and value forecast, 2003?13 (€m, nominal prices) 53 Figure 6: Greece analgesics category growth comparison, by value, 2003?13 56 Figure 7: Greece analgesics company share, by value, 2007?08 (%) 58 Figure 8: Greece analgesics distribution channels, by value, 2007?08 (%) 61 Figure 9: Greece topical OTC medicines value and value forecast, 2003?13 (€m, nominal prices) 64 Figure 10: Greece topical OTC medicines category growth comparison, by value, 2003?13 67 Figure 11: Greece topical OTC medicines distribution channels, by value, 2007?08 (%) 71 Figure 12: Greece cough and cold preparations value and value forecast, 2003?13 (€m, nominal prices) 74 Figure 13: Greece cough and cold preparations category growth comparison, by value, 2003?13 77 Figure 14: Greece cough and cold preparations company share, by value, 2007?08 (%) 79 Figure 15: Greece cough and cold preparations distribution channels, by value, 2007?08 (%) 82 Figure 16: Greece indigestion preparations value and value forecast, 2003?13 (€m, nominal prices) 85 Figure 17: Greece indigestion preparations category growth comparison, by value, 2003?13 87 Figure 18: Greece indigestion preparations company share, by value, 2007?08 (%) 89 Figure 19: Greece indigestion preparations distribution channels, by value, 2007?08 (%) 92 Figure 20: Greece medicated skin products value and value forecast, 2003?13 (€m, nominal prices) 95 Figure 21: Greece medicated skin products category growth comparison, by value, 2003?13 98 Figure 22: Greece medicated skin products company share, by value, 2007?08 (%) 100 Figure 23: Greece medicated skin products distribution channels, by value, 2007?08 (%) 103 Figure 24: Greece first aid kits value and value forecast, 2003?13 (€m, nominal prices) 105 Figure 25: Greece first aid kits company share, by value, 2007?08 (%) 108 Figure 26: Greece first aid kits distribution channels, by value, 2007?08 (%) 111 Figure 27: Greece other OTC healthcare products value and value forecast, 2003?13 (€m, nominal prices) 114 Figure 28: Greece other OTC healthcare products category growth comparison, by value, 2003?13 117 Figure 29: Greece other OTC healthcare products company share, by value, 2007?08 (%) 119 Figure 30: Greece other OTC healthcare products distribution channels, by value, 2007?08 (%) 122 Figure 31: Greece plasters & bandages value and value forecast, 2003?13 (€m, nominal prices) 125 Figure 32: Greece plasters & bandages category growth comparison, by value, 2003?13 128 Figure 33: Greece plasters & bandages company share, by value, 2007?08 (%) 130 Figure 34: Greece plasters & bandages distribution channels, by value, 2007?08 (%) 133 Figure 35: Greece traditional medicines value and value forecast, 2003?13 (€m, nominal prices) 135 Figure 36: Greece traditional medicines distribution channels, by value, 2007?08 (%) 140 Figure 37: Greece vitamins and minerals value and value forecast, 2003?13 (€m, nominal prices) 143 Figure 38: Greece vitamins and minerals category growth comparison, by value, 2003?13 145 Figure 39: Greece vitamins and minerals company share, by value, 2007?08 (%) 148 Figure 40: Greece vitamins and minerals distribution channels, by value, 2007?08 (%) 151 Figure 41: Global OTC healthcare market split (value terms, 2008), top five countries 153 Figure 42: Global OTC healthcare market value, 2003–08, top five countries 155 Figure 43: Annual data review process 186 LIST OF TABLES Table 1: OTC healthcare category definitions 15 Table 2: OTC healthcare distribution channels 17 Table 3: Greece OTC healthcare value, 2003?08 (€m, nominal prices) 31 Table 4: Greece OTC healthcare value forecast, 2008?13 (€m, nominal prices) 32 Table 5: Greece OTC healthcare value, 2003?08 ($m, nominal prices) 34 Table 6: Greece OTC healthcare value forecast, 2008?13 ($m, nominal prices) 35 Table 7: Greece OTC healthcare brand share, by value, 2007?08 (%) 37 Table 8: Greece OTC healthcare value, by brand 2007?08 (€m, nominal prices) 39 Table 9: Greece OTC healthcare company share by value, 2007?08 (%) 42 Table 10: Greece OTC healthcare value, by company, 2007?08 (€m, nominal prices) 43 Table 11: Greece OTC healthcare distribution channels, by value, 2007?08 (%) 44 Table 12: Greece OTC healthcare value, by distribution channel, 2007?08 (€m, nominal prices) 44 Table 13: Johnson & Johnson key facts 46 Table 14: Bayer AG key facts 48 Table 15: Greece analgesics value, 2003?08 (€m, nominal prices) 51 Table 16: Greece analgesics value forecast, 2008?13 (€m, nominal prices) 52 Table 17: Greece analgesics value, 2003?08 ($m, nominal prices) 54 Table 18: Greece analgesics value forecast, 2008?13 ($m, nominal prices) 55 Table 19: Greece analgesics brand share, by value, 2007?08 (%) 57 Table 20: Greece analgesics value, by brand 2007?08 (€m, nominal prices) 57 Table 21: Greece analgesics company share by value, 2007?08 (%) 59 Table 22: Greece analgesics value, by company, 2007?08 (€m, nominal prices) 59 Table 23: Greece analgesics distribution channels, by value, 2007?08 (%) 60 Table 24: Greece analgesics value, by distribution channel, 2007?08 (€m, nominal prices) 60 Table 25: Greece topical OTC medicines value, 2003?08 (€m, nominal prices) 62 Table 26: Greece topical OTC medicines value forecast, 2008?13 (€m, nominal prices) 63 Table 27: Greece topical OTC medicines value, 2003?08 ($m, nominal prices) 65 Table 28: Greece topical OTC medicines value forecast, 2008?13 ($m, nominal prices) 66 Table 29: Greece topical OTC medicines brand share, by value, 2007?08 (%) 68 Table 30: Greece topical OTC medicines value, by brand 2007?08 (€m, nominal prices) 68 Table 31: Greece topical OTC medicines company share by value, 2007?08 (%) 69 Table 32: Greece topical OTC medicines value, by company, 2007?08 (€m, nominal prices) 69 Table 33: Greece topical OTC medicines distribution channels, by value, 2007?08 (%) 70 Table 34: Greece topical OTC medicines value, by distribution channel, 2007?08 (€m, nominal prices) 70 Table 35: Greece cough and cold preparations value, 2003?08 (€m, nominal prices) 72 Table 36: Greece cough and cold preparations value forecast, 2008?13 (€m, nominal prices) 73 Table 37: Greece cough and cold preparations value, 2003?08 ($m, nominal prices) 75 Table 38: Greece cough and cold preparations value forecast, 2008?13 ($m, nominal prices) 76 Table 39: Greece cough and cold preparations brand share, by value, 2007?08 (%) 78 Table 40: Greece cough and cold preparations value, by brand 2007?08 (€m, nominal prices) 78 Table 41: Greece cough and cold preparations company share by value, 2007?08 (%) 80 Table 42: Greece cough and cold preparations value, by company, 2007?08 (€m, nominal prices) 80 Table 43: Greece cough and cold preparations distribution channels, by value, 2007?08 (%) 81 Table 44: Greece cough and cold preparations value, by distribution channel, 2007?08 (€m, nominal prices) 81 Table 45: Greece indigestion preparations value, 2003?08 (€m, nominal prices) 83 Table 46: Greece indigestion preparations value forecast, 2008?13 (€m, nominal prices) 84 Table 47: Greece indigestion preparations value, 2003?08 ($m, nominal prices) 86 Table 48: Greece indigestion preparations value forecast, 2008?13 ($m, nominal prices) 86 Table 49: Greece indigestion preparations brand share, by value, 2007?08 (%) 88 Table 50: Greece indigestion preparations value, by brand 2007?08 (€m, nominal prices) 88 Table 51: Greece indigestion preparations company share by value, 2007?08 (%) 90 Table 52: Greece indigestion preparations value, by company, 2007?08 (€m, nominal prices) 90 Table 53: Greece indigestion preparations distribution channels, by value, 2007?08 (%) 91 Table 54: Greece indigestion preparations value, by distribution channel, 2007?08 (€m, nominal prices) 91 Table 55: Greece medicated skin products value, 2003?08 (€m, nominal prices) 93 Table 56: Greece medicated skin products value forecast, 2008?13 (€m, nominal prices) 94 Table 57: Greece medicated skin products value, 2003?08 ($m, nominal prices) 96 Table 58: Greece medicated skin products value forecast, 2008?13 ($m, nominal prices) 97 Table 59: Greece medicated skin products brand share, by value, 2007?08 (%) 99 Table 60: Greece medicated skin products value, by brand 2007?08 (€m, nominal prices) 99 Table 61: Greece medicated skin products company share by value, 2007?08 (%) 101 Table 62: Greece medicated skin products value, by company, 2007?08 (€m, nominal prices) 101 Table 63: Greece medicated skin products distribution channels, by value, 2007?08 (%) 102 Table 64: Greece medicated skin products value, by distribution channel, 2007?08 (€m, nominal prices) 102 Table 65: Greece first aid kits value, 2003?08 (€m, nominal prices) 104 Table 66: Greece first aid kits value forecast, 2008?13 (€m, nominal prices) 105 Table 67: Greece first aid kits value, 2003?08 ($m, nominal prices) 106 Table 68: Greece first aid kits value forecast, 2008?13 ($m, nominal prices) 106 Table 69: Greece first aid kits brand share, by value, 2007?08 (%) 107 Table 70: Greece first aid kits value, by brand 2007?08 (€m, nominal prices) 107 Table 71: Greece first aid kits company share by value, 2007?08 (%) 109 Table 72: Greece first aid kits value, by company, 2007?08 (€m, nominal prices) 109 Table 73: Greece first aid kits distribution channels, by value, 2007?08 (%) 110 Table 74: Greece first aid kits value, by distribution channel, 2007?08 (€m, nominal prices) 110 Table 75: Greece other OTC healthcare products value, 2003?08 (€m, nominal prices) 112 Table 76: Greece other OTC healthcare products value forecast, 2008?13 (€m, nominal prices) 113 Table 77: Greece other OTC healthcare products value, 2003?08 ($m, nominal prices) 115 Table 78: Greece other OTC healthcare products value forecast, 2008?13 ($m, nominal prices) 116 Table 79: Greece other OTC healthcare products brand share, by value, 2007?08 (%) 118 Table 80: Greece other OTC healthcare products value, by brand 2007?08 (€m, nominal prices) 118 Table 81: Greece other OTC healthcare products company share by value, 2007?08 (%) 120 Table 82: Greece other OTC healthcare products value, by company, 2007?08 (€m, nominal prices) 120 Table 83: Greece other OTC healthcare products distribution channels, by value, 2007?08 (%) 121 Table 84: Greece other OTC healthcare products value, by distribution channel, 2007?08 (€m, nominal prices) 121 Table 85: Greece plasters & bandages value, 2003?08 (€m, nominal prices) 123 Table 86: Greece plasters & bandages value forecast, 2008?13 (€m, nominal prices) 124 Table 87: Greece plasters & bandages value, 2003?08 ($m, nominal prices) 126 Table 88: Greece plasters & bandages value forecast, 2008?13 ($m, nominal prices) 127 Table 89: Greece plasters & bandages brand share, by value, 2007?08 (%) 129 Table 90: Greece plasters & bandages value, by brand 2007?08 (€m, nominal prices) 129 Table 91: Greece plasters & bandages company share by value, 2007?08 (%) 131 Table 92: Greece plasters & bandages value, by company, 2007?08 (€m, nominal prices) 131 Table 93: Greece plasters & bandages distribution channels, by value, 2007?08 (%) 132 Table 94: Greece plasters & bandages value, by distribution channel, 2007?08 (€m, nominal prices) 132 Table 95: Greece traditional medicines value, 2003?08 (€m, nominal prices) 134 Table 96: Greece traditional medicines value forecast, 2008?13 (€m, nominal prices) 135 Table 97: Greece traditional medicines value, 2003?08 ($m, nominal prices) 136 Table 98: Greece traditional medicines value forecast, 2008?13 ($m, nominal prices) 136 Table 99: Greece traditional medicines brand share, by value, 2007?08 (%) 137 Table 100: Greece traditional medicines value, by brand 2007?08 (€m, nominal prices) 137 Table 101: Greece traditional medicines company share by value, 2007?08 (%) 138 Table 102: Greece traditional medicines value, by company, 2007?08 (€m, nominal prices) 138 Table 103: Greece traditional medicines distribution channels, by value, 2007?08 (%) 139 Table 104: Greece traditional medicines value, by distribution channel, 2007?08 (€m, nominal prices) 139 Table 105: Greece vitamins and minerals value, 2003?08 (€m, nominal prices) 141 Table 106: Greece vitamins and minerals value forecast, 2008?13 (€m, nominal prices) 142 Table 107: Greece vitamins and minerals value, 2003?08 ($m, nominal prices) 144 Table 108: Greece vitamins and minerals value forecast, 2008?13 ($m, nominal prices) 144 Table 109: Greece vitamins and minerals brand share, by value, 2007?08 (%) 146 Table 110: Greece vitamins and minerals value, by brand 2007?08 (€m, nominal prices) 147 Table 111: Greece vitamins and minerals company share by value, 2007?08 (%) 149 Table 112: Greece vitamins and minerals value, by company, 2007?08 (€m, nominal prices) 149 Table 113: Greece vitamins and minerals distribution channels, by value, 2007?08 (%) 150 Table 114: Greece vitamins and minerals value, by distribution channel, 2007?08 (€m, nominal prices) 150 Table 115: Global OTC healthcare market value, 2008 152 Table 116: Global OTC healthcare market split (value terms ($m), 2008), top five countries 155 Table 117: Leading players, top five countries 156 Table 118: Analysis of Greece’s political landscape 158 Table 119: Analysis of Greece’s economy 162 Table 120: Analysis of Greece’s social system 166 Table 121: Analysis of Greece’s technology landscape 169 Table 122: Hourly labor cost in EU countries (in Euros) 170 Table 123: Patents granted by USPTO 172 Table 124: Analysis of Greece’s legal landscape 173 Table 125: Analysis of Greece’s environmental landscape 177 Table 126: Greece population, by age group, 2003?08 (millions) 180 Table 127: Greece population forecast, by age group, 2008?13 (millions) 181 Table 128: Greece population, by gender, 2003?08 (millions) 181 Table 129: Greece population forecast, by gender, 2008?13 (millions) 182 Table 130: Greece nominal GDP, 2003?08 (€bn, nominal prices) 182 Table 131: Greece nominal GDP forecast, 2008?13 (€bn, nominal prices) 182 Table 132: Greece real GDP, 2003?08 (€bn, 2000 prices) 183 Table 133: Greece real GDP forecast, 2008?13 (€bn, 2000 prices) 183 Table 134: Greece real GDP, 2003?08 ($bn, 2000 prices) 183 Table 135: Greece real GDP forecast, 2008?13 ($bn, 2000 prices) 184 Table 136: Greece consumer price index, 2003?08 (2000=100) 184 Table 137: Greece consumer price index, 2008?13 (2000=100) 184 [Inhaltsverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||


